CClinicalTrials.gg
CompletedNCT02399761Updated Apr 28, 2017

Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency

An observational study in Aromatic L-amino Acid Decarboxylase Deficiency, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged Up to 3 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-28.

Sponsored by National Taiwan University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
154,795
Ages
Up to 3 Months
Sex
All
01

Study summary

Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency.

Read the detailed description

Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency. The routine newborn screening dried blood spots sample will be used to test if 3-O-methyldopa (3-OMD) concentration elevates. If positive of screening test, further confirmation tests including physical examination and for mutation. Genetic counseling and treatment option will be provided, too.

02

Conditions studied

  • Aromatic L-amino Acid Decarboxylase Deficiency

Keywords

  • AADC deficiency, newborn screening
03

In context

Amino Acid Metabolism, Inborn Errors

29 studies on the registry are indexed under Amino Acid Metabolism, Inborn Errors; 8 are open to participants now.

This study's enrollment of 154,795 is above the median of 60 across 11 observational studies indexed under Amino Acid Metabolism, Inborn Errors.

Browse Amino Acid Metabolism, Inborn Errors studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 3 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

newborns whose parents agree to be tested

Inclusion criteria

  • Babies born in Taiwan receive regular new born screening suggested by Ministry of Heath and Welfare.
  • Parents or Legal Guardian sign in the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Parents or Legal Guardian do not agree to sign in the informed consent form.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
154,795 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Number of newborns with AADC deficiency

    Time frame: 3 years

07

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02399761
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Mar 26, 2015
Start date
Aug 2012
Primary completion
Jul 2016
Completion
Jul 2016
Last update
Apr 28, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion